At ENPICOM we want to provide the best possible experience for our customers while also managing our operating expenses. We depend on AWS cloud for hosting our IGX Platform and for supporting our research initiatives.
In this blog, we will discuss display technologies, enrichment analysis, and how the IGX Platform can help you make the best out of your display-based antibody discovery campaigns.
Traditional animal models such as mice, rats, and rabbits are commonly used in antibody discovery for therapeutic, diagnostic, and research purposes. They are cost-effective, versatile, and widely accepted in research settings.
Discover how you can use structural modeling to identify antibody liabilities and developability profiles for thousands of sequences at once.
By democratizing Rep-Seq data analysis, scientists and collaborators can extract value directly from all data, avoiding bottlenecks that hinder innovation and development.
NGS of BCR repertoires is crucial in antibody discovery and vaccine studies, allowing for detailed immune response analysis. Prof. Gunilla Karlsson Hedestam discussed the impact of high-throughput Rep-Seq on antibody and vaccine discovery.
Biomedical software needs good UX practices to tackle complex research questions. Discover how well-thought interface and experience can significantly improve and speed up biomedical data analysis.
Single-cell sequencing technology has been applied in many biomedical fields, including immunology. In this post, we take a closer look at the market, forecasts, and highlight expert insights from the single-cell immune profiling industry.
Prof. Dirk Busch and Dr. Kilian Schober from the Technical University of Munich use T-cell receptor sequencing to study the T-cell response during CMV infection in humans and mice.
Explore how repertoire sequencing advances research in infectious diseases and the future of immunomics-driven therapy development.
ENPICOM